drugset / Trial / NCT00270491
Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.
RandomizedParallel-groupOpen-labelTreatment
Summary
Tolerance and efficacy of administration of capecitabine 5 out of 7 days associated with weekly paclitaxel compared to the recommended treatment plan of weekly paclitaxel - capecitabine, in patients with metastatic breast cancer.
Timeline
- Start
- 2005-12
- Primary completion
- 2009-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |